Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non–small cell lung cancer

Liza C. Villaruz, George R. Blumenschein, Gregory A. Otterson, Ticiana A. Leal

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non–small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences